Airway Pressure Release Ventilation for Acute Respiratory Failure Due to Coronavirus Disease 2019: A Systematic Review and Meta-Analysis

Abstract

Objective: To explore the evidence surrounding the use of Airway Pressure Release Ventilation (APRV) in patients with coronavirus disease 2019 (COVID-19). Methods: A Systematic electronic search of PUBMED, EMBASE, and the WHO COVID-19 database. We also searched the grey literature via Google and preprint servers (medRxive and research square). Eligible studies included randomised controlled trials and observational studies comparing APRV to conventional mechanical ventilation (CMV) in adults with acute hypoxemic respiratory failure due to COVID-19 and reporting at least one of the following outcomes; in-hospital mortality, ventilator free days (VFDs), ICU length of stay (LOS), changes in gas exchange parameters, and barotrauma. Two authors independently screened and selected articles for inclusion and extracted data in a pre-specified form. Results: Of 181 articles screened, seven studies (one randomised controlled trial, two cohort studies, and four before-after studies) were included comprising 354 patients. APRV was initiated at a mean of 1.2-13 days after intubation. APRV wasn’t associated with improved mortality compared to CMV (relative risk [RR], 1.20; 95% CI 0.70-2.05; I², 61%) neither better VFDs (ratio of means [RoM], 0.80; 95% CI, 0.52-1.24; I², 0%) nor ICU LOS (RoM, 1.10; 95% CI, 0.79-1.51; I², 57%). Compared to CMV, APRV was associated with a 33% increase in PaO₂/FiO₂ ratio (RoM, 1.33; 95% CI, 1.21-1.48; I², 29%) and a 9% decrease in PaCO₂ (RoM, 1.09; 95% CI, 1.02-1.15; I², 0%). There was no significant increased risk of barotrauma compared to CMV (RR, 1.55; 95% CI, 0.60-4.00; I², 0%). Conclusions: In adult patients with COVID-19 requiring mechanical ventilation, APRV is associated with improved gas exchange but not mortality nor VFDs when compared with CMV. The results were limited by high uncertainty given the low quality of the available studies and limited number of patients. Adequately powered and well-designed clinical trials to define the role of APRV in COVID-19 patients are still needed. Registration: PROSPERO; CRD42021291234.

Keywords

COVID-19 airway pressure release ventilation mechanical ventilation respiratory failure ARDS

Get full access to this article

View all access options for this article.

References

Lim

Subramaniam

Ponnapa Reddy

, et al. Case fatality rates for patients with COVID-19 requiring invasive mechanical ventilation. A meta-analysis. Am J Respir Crit Care Med. 2021;203(1):54-66.

Stock

Downs

Frolicher

. Airway pressure release ventilation. Crit Care Med. 1987;15(5):462-466.

Jain

Kollisch-Singule

Sadowitz

, et al. The 30-year evolution of airway pressure release ventilation (APRV). Intensive Care Med Exp. 2016;4(1):11.

Carsetti

Damiani

Domizi

, et al. Airway pressure release ventilation during acute hypoxemic respiratory failure: a systematic review and meta-analysis of randomized controlled trials. Ann Intensive Care. 2019;9(1):44.

Lim

Litton

. Airway pressure release ventilation in adult patients with acute hypoxemic respiratory failure: a systematic review and meta-analysis. Crit Care Med. 2019;47(12):1794-1799.

Othman

Alsagami

Alharbi

Almuammer

Alshahrani

Ismaeil

. The efficacy of airway pressure release ventilation in acute respiratory distress syndrome adult patients: a meta-analysis of clinical trials. Ann Thorac Med. 2021;16(3):245-252.

Sun

Liu

You

Zhao

. The safety and efficacy of airway pressure release ventilation in acute respiratory distress syndrome patients: a PRISMA-compliant systematic review and meta-analysis. Medicine (Baltimore). 2020;99(1):e18586.

Badulak

Antonini

Stead

, et al. Extracorporeal membrane oxygenation for COVID-19: updated 2021 guidelines from the extracorporeal life support organization. ASAIO J. 2021;67(5):485-495.

Tonna

Abrams

Brodie

, et al. Management of adult patients supported with venovenous extracorporeal membrane oxygenation (VV ECMO): guideline from the extracorporeal life support organization (ELSO). ASAIO J. 2021;67(6):601-610.

10.

Miller

Gentile

Davies

MacIntyre

. Clinical management strategies for airway pressure release ventilation: a survey of clinical practice. Respir Care. 2017;62(10):1264-1268.

11.

Page

McKenzie

Bossuyt

, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. Br Med J. 29;2021:372:n71.

12.

Sterne

JAC

Savovic

Page

, et al. Rob 2: a revised tool for assessing risk of bias in randomised trials. Br Med J. 2019;366:l4898.

13.

Wells

Shea

O'Connell

, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. The Ottawa Hospital Research Institute. Available at: http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp. Accessed December 1, 2021.

14.

National Institutes of Health. Quality Assessment Tool for Before-After (Pre-Post) Studies With No Control Group. National Institutes of Health Web site. Available at: https://www.nhlbi.nih.gov/health-topics/study-quality-assessment-tools. Accessed December 1, 2021.

15.

Friedrich

Adhikari

Beyene

. The ratio of means method as an alternative to mean differences for analyzing continuous outcome variables in meta-analysis: a simulation study. BMC Med Res Methodol. 2008;8:32.

16.

Wan

Wang

Liu

Tong

. Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range. BMC Med Res Methodol. 2014;14:135.

17.

Ibarra-Estrada

Garcia-Salas

Mireles-Cabodevila

, et al. Use of airway pressure release ventilation in patients with acute respiratory failure due to coronavirus disease 2019: results of a single-center randomized controlled trial. Crit Care Med. 2021;50(4):586-594.

18.

Jain

Londono

Uribe-Marquez

Nowak

. Conventional protective LTV versus APRV for patients with severe COVID-19 disease. Crit Care Med. 2021;49(SUPPL 1):68.

19.

Zorbas

Litton

Wibrow

Fysh

Anstey

. Airway pressure release ventilation in mechanically ventilated patients with COVID-19: a multicenter observational study. Acute Crit Care. 2021;36(2):143-150.

20.

Joseph

DAK

Baltazar

Jacquez

, et al. A pilot study of patients with COVID–19-related respiratory failure utilizing airway pressure release ventilation (APRV). Innovations in Surgery and Interventional Medicine. 2020;1(1):3-8.

21.

Koszutski

Pequignot

Kimmoun

Remen

Guerci

Levy

. Implementation and feasibility of inverse-ratio Airway Pressure Release Ventilation (APRV): Switching from Conventional Ventilation to APRV in Two French ICUs. PREPRINT (Version 1),16 Dec 2020. Available at: Research Square. [https://doi.org/10.21203/rs.3.rs-127683/v1]. Accessed 16 Oct, 2021.

22.

Mahmoud

Patadia

Salonia

. Utilization of airway pressure release ventilation as a rescue strategy in COVID-19 patients: a retrospective analysis. J Intensive Care Med. 2021;36(10):1194-1200.

23.

Sathyanarayanan

Hamid

Hamza

Jamous

. Airway pressure release ventilation use in COVID-19 ARDS: a single center observational study. Chest. 2021;160(4):A1089-A1090.

24.

Zhou

Jin

, et al. Early application of airway pressure release ventilation may reduce the duration of mechanical ventilation in acute respiratory distress syndrome. Intensive Care Med. 2017;43(11):1648-1659.

25.

Papazian

Forel

Gacouin

, et al. Neuromuscular blockers in early acute respiratory distress syndrome. N Engl J Med. 2010;363(12):1107-1116.

26.

National Heart Lung and Blood Institute PETAL Clinical Trials Network, Moss

Huang

, et al. Early neuromuscular blockade in the acute respiratory distress syndrome. N Engl J Med. 2019;380(21):1997-2008.

27.

Guerin

. Prone ventilation in acute respiratory distress syndrome. Eur Respir Rev. 2014;23(132):249-257.

28.

Gebistorf

Karam

Wetterslev

Afshari

. Inhaled nitric oxide for acute respiratory distress syndrome (ARDS) in children and adults. Cochrane Database Syst Rev. 2016(6):CD002787.

29.

Matthews

Baker

Ferrari

, et al. Compassionate use of pulmonary vasodilators in acute severe hypoxic respiratory failure due to COVID-19. J Intensive Care Med. 2022:8850666221086521.

30.

Acute Respiratory Distress Syndrome Network, Brower

Matthay

, et al. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med. 2000;342(18):1301-1308.

31.

Writing Group for the Alveolar Recruitment for Acute Respiratory Distress Syndrome Trial I, Cavalcanti

Suzumura

, et al. Effect of lung recruitment and titrated positive end-expiratory pressure (PEEP) vs low PEEP on mortality in patients with acute respiratory distress syndrome: a randomized clinical trial. JAMA. 2017;318(14):1335-1345.

32.

Guo

Xie

Huang

, et al. Higher PEEP improves outcomes in ARDS patients with clinically objective positive oxygenation response to PEEP: a systematic review and meta-analysis. BMC Anesthesiol. 2018;18(1):172.

33.

Hirshberg

Lanspa

Peterson

, et al. Randomized feasibility trial of a low tidal volume-airway pressure release ventilation protocol compared with traditional airway pressure release ventilation and volume control ventilation protocols. Crit Care Med. 2018;46(12):1943-1952.

34.

Nieman

Andrews

Satalin

, et al. Acute lung injury: how to stabilize a broken lung. Crit Care. 2018;22(1):136.

35.

Weerakkody

Arina

Glenister

, et al. Non-invasive respiratory support in the management of acute COVID-19 pneumonia: considerations for clinical practice and priorities for research. Lancet Respir Med. 2022;10(2):199-213.

36.

Perkins

Connolly

, et al. Effect of noninvasive respiratory strategies on intubation or mortality among patients with acute hypoxemic respiratory failure and COVID-19: the RECOVERY-RS randomized clinical trial. JAMA. 2022;327(6):546-558.

37.

Cressoni

Chiumello

Algieri

, et al. Opening pressures and atelectrauma in acute respiratory distress syndrome. Intensive Care Med. 2017;43(5):603-611.

38.

Mireles-Cabodevila

Dugar

Chatburn

. APRV For ARDS: the complexities of a mode and how it affects even the best trials. J Thorac Dis. 2018;10(Suppl 9):S1058-S1063.

39.

Hermann

Laxar

Krall

, et al. Duration of invasive mechanical ventilation prior to extracorporeal membrane oxygenation is not associated with survival in acute respiratory distress syndrome caused by coronavirus disease 2019. Ann Intensive Care. 2022;12(1):6.

40.

Ramanathan

Shekar

Ling

, et al. Extracorporeal membrane oxygenation for COVID-19: a systematic review and meta-analysis. Crit Care. 2021;25(1):211.

41.

von Hippel

. The heterogeneity statistic I(2) can be biased in small meta-analyses. BMC Med Res Methodol. 2015;15:35.

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.00 MB

0.06 MB